Literature DB >> 9882523

Transcriptional induction of the p69 isoform of 2',5'-oligoadenylate synthetase by interferon-beta and interferon-gamma involves three regulatory elements and interferon-stimulated gene factor 3.

G Floyd-Smith1, Q Wang, G C Sen.   

Abstract

The 2',5'-oligoadenylate synthetases are key enzymes that mediate antiviral actions of interferon (IFN). The mRNAs for the intermediate isoforms (p69) of human 2',5'-oligoadenylate synthetase are rapidly induced 10- to 20-fold in HT1080 glioma cells by IFN-beta and induced 3-fold at 24 h by IFN-gamma. Induction is mediated by three regulatory elements, an IFN-stimulated response element and two identical sites resembling interferon response factor binding sites that are located within 300 bp of the transcriptional start site. Maximal induction requires all three elements, yet mutation in the most distal IRF-1-like site diminishes transcription only slightly. Mutation in the ISRE substantially decreases constitutive expression but does not abrogate the response to IFNs. Simultaneous mutation in all three elements abolishes responsiveness to both IFN-beta and IFN-gamma. Both constitutive and IFN-beta-induced expression from the p69 promoter is blocked in mutant cell lines deficient in components of the transcription factor, interferon-stimulated gene factor 3, suggesting that it is the primary factor controlling IFN-beta induced expression of this gene. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882523     DOI: 10.1006/excr.1998.4296

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

1.  Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

2.  Could 2'5'-oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients? A pilot study.

Authors:  Shuang Ye; Qiang Guo; Jiang-Ping Tang; Cheng-de Yang; Nan Shen; Shun-le Chen
Journal:  Clin Rheumatol       Date:  2006-03-25       Impact factor: 2.980

3.  OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses.

Authors:  Jonathan J Rios; Joann G W Fleming; Uneeda K Bryant; Craig N Carter; John C Huber; Maureen T Long; Thomas E Spencer; David L Adelson
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

4.  Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Authors:  Shin-Ichiro Kawamoto; Kenji Oritani; Hideo Asada; Isao Takahashi; Jun Ishikawa; Hitoshi Yoshida; Masahide Yamada; Naoko Ishida; Hidetoshi Ujiie; Hiroaki Masaie; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Viral induction of the zinc finger antiviral protein is IRF3-dependent but NF-kappaB-independent.

Authors:  Nan Wang; Qingming Dong; Jingjing Li; Rohit K Jangra; Meiyun Fan; Allan R Brasier; Stanley M Lemon; Lawrence M Pfeffer; Kui Li
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.